296 related articles for article (PubMed ID: 17538118)
1. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored.
Leuenberger D; Andresen PA; Gosert R; Binggeli S; Ström EH; Bodaghi S; Rinaldo CH; Hirsch HH
Clin Vaccine Immunol; 2007 Aug; 14(8):959-68. PubMed ID: 17538118
[TBL] [Abstract][Full Text] [Related]
2. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients.
Binggeli S; Egli A; Schaub S; Binet I; Mayr M; Steiger J; Hirsch HH
Am J Transplant; 2007 May; 7(5):1131-9. PubMed ID: 17359507
[TBL] [Abstract][Full Text] [Related]
3. BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.
Schachtner T; Müller K; Stein M; Diezemann C; Sefrin A; Babel N; Reinke P
Am J Transplant; 2011 Nov; 11(11):2443-52. PubMed ID: 21831150
[TBL] [Abstract][Full Text] [Related]
4. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.
Bodaghi S; Comoli P; Bösch R; Azzi A; Gosert R; Leuenberger D; Ginevri F; Hirsch HH
J Clin Microbiol; 2009 Aug; 47(8):2577-85. PubMed ID: 19474265
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.
Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ
Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells.
Sharma BN; Li R; Bernhoff E; Gutteberg TJ; Rinaldo CH
Antiviral Res; 2011 Oct; 92(1):115-23. PubMed ID: 21798289
[TBL] [Abstract][Full Text] [Related]
8. Polyomavirus-associated nephropathy: update on BK virus-specific immunity.
Comoli P; Binggeli S; Ginevri F; Hirsch HH
Transpl Infect Dis; 2006 Jun; 8(2):86-94. PubMed ID: 16734631
[TBL] [Abstract][Full Text] [Related]
9. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
Drachenberg CB; Hirsch HH; Papadimitriou JC; Gosert R; Wali RK; Munivenkatappa R; Nogueira J; Cangro CB; Haririan A; Mendley S; Ramos E
Transplantation; 2007 Aug; 84(3):323-30. PubMed ID: 17700156
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.
Zhou W; Sharma M; Martinez J; Srivastava T; Diamond DJ; Knowles W; Lacey SF
Viral Immunol; 2007 Sep; 20(3):379-88. PubMed ID: 17931108
[TBL] [Abstract][Full Text] [Related]
11. Cellular immune responses to BK virus.
Comoli P; Hirsch HH; Ginevri F
Curr Opin Organ Transplant; 2008 Dec; 13(6):569-74. PubMed ID: 19060544
[TBL] [Abstract][Full Text] [Related]
12. Comparing effects of BK virus agnoprotein and herpes simplex-1 ICP47 on MHC-I and MHC-II expression.
Cioni M; Mittelholzer C; Wernli M; Hirsch HH
Clin Dev Immunol; 2013; 2013():626823. PubMed ID: 23606871
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.
Krymskaya L; Sharma MC; Martinez J; Haq W; Huang EC; Limaye AP; Diamond DJ; Lacey SF
J Virol; 2005 Sep; 79(17):11170-8. PubMed ID: 16103168
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation.
Fan Y; Bai H; Qian Y; Sun Z; Shi B
Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648
[TBL] [Abstract][Full Text] [Related]
15. BK-VP3 as a new target of cellular immunity in BK virus infection.
Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N
Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414
[TBL] [Abstract][Full Text] [Related]
16. Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy.
Tremolada S; Akan S; Otte J; Khalili K; Ferrante P; Chaudhury PR; Woodle ES; Trofe-Clark J; White MK; Gordon J
Virology; 2010 Sep; 404(2):312-8. PubMed ID: 20554301
[TBL] [Abstract][Full Text] [Related]
17. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation.
Bae H; Jung S; Chung BH; Yang CW; Oh EJ
Front Immunol; 2023; 14():1243912. PubMed ID: 37809095
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant IgG antibodies to polyoma BK virus in pediatric renal transplants.
Bijol V; Cimic A; Viscidi RP; Hymes LC
Pediatr Transplant; 2010 Mar; 14(2):224-7. PubMed ID: 19496978
[TBL] [Abstract][Full Text] [Related]
20. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
